![Ebun Garner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ebun Garner
General Counsel at
ERASCA, INC.
Net worth: 367 614 $ as of 2026-09-29
Profile
Mr. Ebun S.
Garner is a Chief Legal Officer at Erasca, Inc. Mr. Garner was previously employed as an Assistant General Counsel by ACADIA Pharmaceuticals, Inc., a Secretary & Chief Legal Officer by Imbria Pharmaceuticals, Inc., an Associate General Counsel by Neurocrine Biosciences, Inc., a Secretary, Senior Vice President & General Counsel by Alphatec Holdings, Inc., a Secretary, Senior Vice President & General Counsel by Alphatec Spine, Inc., an Associate by Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC, an Associate by Squadron, Ellenoff, Plesent & Sheinfeld LLP, and a Director General by Scient'x SA. He received his undergraduate degree from the University of Pennsylvania and a graduate degree from New York University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ERASCA, INC. 0.01% | 2026-03-31 | 25,076 ( 0.01% ) | 367 614 $ | 2026-09-29 |
Ebun Garner active positions
| Companies | Position | Start |
|---|---|---|
| ERASCA, INC. | General Counsel | 2021-03-31 |
Former positions of Ebun Garner
| Companies | Position | End |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 2021-03-31 |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | General Counsel | 2020-06-30 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 2019-03-31 |
| ALPHATEC HOLDINGS, INC. | Investor Relations Contact | 2012-07-22 |
Alphatec Spine, Inc.
 Alphatec Spine, Inc. Medical SpecialtiesHealth Technology Designs, manufactures, and sells medical devices for surgical treatment of spine disorders | General Counsel | 2017-02-27 |
Education of Ebun Garner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Alphatec Holdings, Inc.
 Alphatec Holdings, Inc. Medical SpecialtiesHealth Technology Operates as a holding company with interests in medical equipment and supplies | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Squadron, Ellenoff, Plesent & Sheinfeld LLP
 Squadron, Ellenoff, Plesent & Sheinfeld LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Scient'x SA
 Scient'x SA Medical SpecialtiesHealth Technology Designs, develops and markets spinal implant devices for the lumbar, thoracic and cervical spine | Health Technology |
Alphatec Spine, Inc.
Alphatec Spine, Inc. Medical SpecialtiesHealth Technology Designs, manufactures, and sells medical devices for surgical treatment of spine disorders | Health Technology |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
- Stock Market
- Insiders
- Ebun Garner
